NCT07136688 is a NA clinical trial of Stamobil electric stimulator in Neurogenic Bladder Due to Spina Bifida, sponsored by The University of Texas Health Science Center, Houston.

Who is sponsoring NCT07136688?

NCT07136688 is sponsored by The University of Texas Health Science Center, Houston.

What drugs are being tested in NCT07136688?

Interventions in NCT07136688: Stamobil electric stimulator, sham tTNS device.

What condition does NCT07136688 study?

NCT07136688 studies Neurogenic Bladder Due to Spina Bifida.

Is NCT07136688 still recruiting?

NCT07136688 is currently recruiting now. Last updated 8 April 2026.

Last reviewed 2026-04-08 · How we verify

NCT07136688

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tibial Nerve Stimulation for Pediatric Spina Bifida Neurogenic Bladder

Recruiting now NA Last updated 8 April 2026

What this trial tests

NA trial testing Stamobil electric stimulator in Neurogenic Bladder Due to Spina Bifida in 20 participants. Currently enrolling.

Timeline

27 March 2026

Primary endpoint
11 April 2027

11 August 2027

Quick facts

Lead sponsor	The University of Texas Health Science Center, Houston
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	20
Start date	27 March 2026
Primary completion	11 April 2027
Estimated completion	11 August 2027
Sites	1 location across United States

Drugs / interventions tested

Stamobil electric stimulator
sham tTNS device

Conditions studied

Neurogenic Bladder Due to Spina Bifida — all drugs for Neurogenic Bladder Due to Spina Bifida →

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Adults 4 to 17, any sex, with Neurogenic Bladder Due to Spina Bifida. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the safety, feasibility, and compliance of a daily home transcutaneous tibial nerve stimulation (tTNS) protocol in children with chronic neurogenic bladder (NB) provided by self or caregiver for 4 weeks and to estimate the efficacy of tTNS

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07136688 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
Last refreshed: 8 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07136688.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing